$11.98 -0.24 (-1.96%)

LENSAR, Inc. Common Stock (LNSR)

LENSAR, Inc. is a medical technology company specializing in laser systems for ophthalmic surgical procedures, particularly cataract surgery. Known for its advanced laser platforms, the company focuses on improving surgical outcomes and efficiency through innovative laser automation and cutting-edge ophthalmic solutions.

🚫 LENSAR, Inc. Common Stock does not pay dividends

Company News

SpyGlass Pharma Appoints Elizabeth O’Farrell to its Board of Directors
GlobeNewswire Inc. • Patrick Mooney • August 19, 2025

SpyGlass Pharma announced the appointment of Elizabeth O'Farrell to its Board of Directors, bringing over 30 years of healthcare industry experience. She will serve as an Independent Director and Chair of the Audit Committee, supporting the company's advancement of its Drug Delivery Platform for glaucoma management.

$TOCKHOLDER ALERT: The M&A Class Action Firm Encourages Shareholders of SVT, SSBK, LNSR, iCAD to Protect Their Rights
Benzinga • Prnewswire • June 10, 2025

The M&A Class Action Firm is investigating the proposed mergers of Servotronics, Southern States Bancshares, LENSAR, and iCAD, and is encouraging shareholders to protect their rights.

Thermo Fisher Scientific (TMO) Surpasses Q1 Earnings and Revenue Estimates
Zacks Investment Research • Zacks Equity Research • April 28, 2022

Thermo Fisher (TMO) delivered earnings and revenue surprises of 17.50% and 11.17%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?